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These methods are based on the identification of polymorphisms of a single bacterial gene coding for 16S rRNA and comparison of obtained sequences with known sequences listed in taxo nomic databases, in order to assign each polymorphism to a single taxon. This technique (16S rRNA microbial profiling) allows to determine the composition of gut microbiota from both a qualitative (i.e., which taxon is present) and quantitative (i.e., how much it is represented) point of view (46) . The gut microbiota composition of healthy adults is char acterized by a relatively low number of species with high rep resentation (including Bacteroides, Prevotella, Eubacterium, Alistipes) and a large number of species with low relative abun dance but relevant metabolic activity (including Clostridium, Anaerotruncus, Butyrivibrio, Faecalibacterium, Akkermansia) (20) . In adults, this composition is characterized by stability over time and resilience to perturbations (17) .
A certain degree of interindividual variability is also present. Several genetic, environmental and clinical factors influence this variability (35) . These factors include geography, diet, life style, ageing, diseases and drug treatments (50) . The importance of diet as modulator of gut microbiota composition has been particularly emphasized in the scientific literature (29, 47) . A large consumption of animal proteins has been linked with a shift towards expansion of microbial populations belonging to the phylum Bacteroidetes, while consumption of fruit and vege tables induces expansion of microbial populations belonging to Firmicutes (29, 47) . Additionally, several studies performed on both animal models and human beings underline that physical activity and exercise may contribute substantially to increase gut microbiota diversity and limit the expansion of microbial taxa with a potentially harmful effect (7) .
Moreover, during aging, gut microbiota composition is phys iologically characterized by increased interindividual variabil ity, reduced resilience after stressful events and reduced overall number of taxa represented. These alterations are generally em phasized in those subjects with mobilitydisability and residing in nursing homes (14, 19, 21) .
The Systemic Influence of Gut Microbiota
From a medical point of view, alterations in gut microbiota composition have been associated with a large number of di seases, not involving only the gastroenteric system (for example, diabetes, obesity, asthma, Parkinson's disease, chronic kidney disease) (27) . These alterations are generally defined with the term of "dysbiosis", indicating a reduced biodiversity (i.e., lower number of species represented), underexpression of taxa with purported beneficial metabolic activites and overexpression of pathobionts, including gramnegative opportunistic pathogens belonging to Enterobacteriaceae (13) .
However, most of this evidence comes from crosssectional studies, so that it is not possible to determine whether dysbiosis represents a cause, a cofactor, or simply a consequence of sys temic diseases (37) . Moreover, studies exploring the functional profiling of microbial communities and the effects of gut micro biota modulation with probiotics or functional foods are still lacking in several areas of microbiome research (37) .
Nevertheless, the current stateofart allows hypothesiz ing that gut microbiota may influence the physiopathology of several organs outside the gastrointestinal system, including liver, brain, kidneys, lungs and bones (31) . Several possible mechanisms may be involved (43) , listed in Table 1 . Among these mechanisms, the gut microbiotainduced modula tion of systemic inflammation seems fundamental (25) .
A dysbiotic gut microbiota may in fact produce proinflam matory metabolites or toxins, like lipopolysaccharide (LPS), absorbed by intestinal epithelium, or promote reduction of gut mucosa permeability ("leaky gut"), allowing bacteria to enter circulation (25) .
For example, several studies performed on animal mod els support a link between dysbiosis and many aspects of the physiopathology of dementia ("gutbrain axis"), including the capacity to promote neuroinflammation (43) . Although stud ies on human beings are scarce, the role of gut microbiota in modulation of brain function has already been demonstrated in hepatic encephalopathy (4) . Dysbiosis may also influence kidney function ("gutkidney axis") in chronic kidney disease progres sion (12) , and even the formation of kidney stones, implying a reduced representation of bacteria degrading oxalate, which is the main component of stones (41) . Recent evidence also sup ports the existence of a "gutbone axis", since the administration of a probiotic containing Lactobacillus reuteri can be associated with a reduction of the agerelated bone mineral density loss in older women (33) .
The Gut-Muscle Axis In Muscle Wasting Disorders
In this scenario of increasing evidence that gut microbiota may influence the physiopathology of distant organs, three research groups have independently hypothesized that a "gutmuscle axis" also exists, particularly in the onset and clinical course of agerelated sarcopenia (18, 34, 39) . In older people, sarcope nia has been defined as an agerelated reduction of muscle strength and quantity or quality in the absence of any identifi able single underlying cause (15) . It has a prevalence of 1525% in communitydwellers over 70 years of age, with peaks of up to 50% in subjects over 85 years old admitted to hospital for acu te diseases (28) . It also represents a frequent complication of hospital stay in older people, and is frequently associated with frailty, multimorbidity and poor quality of life (8) . The clinical relevance of sarcopenia mainly depends on its capacity to pre dict functional disability and mortality, justifying its label as a "geriatric giant" (6) .
From a physiopathological point of view, sarcopenia is a multifactorial condition influenced by immobility, physical activity, malnutrition, malabsorption, agerelated motor neu ron losses, and endocrine factors physiologically occurring with aging, including insulin resistance, abnormal thyroid function, reduced growth hormone and reduced sexual hormone syn thesis (23) . However, a central role is played by chronic sys temic inflammation. This mechanism alone is able to reduce insulin sensitivity, promote a shift towards muscle protein degradation at the expense of protein synthesis, reduce mus cle mitochondrial biogenesis and function, and impair muscle capillarity, ultimately leading to reduced muscle mass and function (16) . Sarcopenic patients in fact have increased levels of serum Creactive protein (CRP), although studies on other inflammatory mediators, such as interleukin6, have not given clear results (5) . Moreover, an aged immune system and inade quate nutrition may play a central role in stimulating chronic inflammation activation, and thus support the maintenance of sarcopenia (40, 49) .
All these physiopathologic elements may be influenced by the gut microbiota. In older subjects, gut microbiota composition may represent a marker of health status and probably a predictor of health decline and mortality (42) . The frailty index, a clinical measure of fitness, is associat ed with gut microbiota dysbiosis, characterized by reduced GERMAN JOURNAL OF SPORTS MEDICINE 69 12/2018
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representation of taxa with possible antiinflammatory ef fects (such as Faecalibacterium prausnitzii) and blooming of pathobionts (21) .
In this context, the gut microbiota may influence the skeletal muscle metabolism through multiple mechanisms, summarized in table 1.
First, gut microbiota has a welldemonstrated capacity of modulating the anaboliccatabolic balance. Germfree mice exhibit a persistently lean phenotype even when fed a highfat diet (3). Conversely, the transplantation of fecal microbiota from malnourished Malawian children to germfree mice resulted in mouse failuretothrive, underlying that gut microbiota rep resents a fundamental transducer of proanabolic stimuli from diet to the host organs and tissues (9) . Moreover, the adminis tration of a probiotic blend containing Lactobacillus reuteri to transgenic mice genetically prone to muscle wasting and ca chexia resulted in a significant improvement in muscle mass and size and in prevention of agerelated decline of muscle mass (45) .
Second, several metabolites produced by the gut microbiota can be absorbed by the gut mucosa and influence the skeletal muscle physiology (39) . Some of these are used by the host as nutrients, and include folic acid, riboflavin, vitamin B12, glycine betaine and some amino acids. These nutrients have different effects on skeletal muscle physiology, ranging from promotion of DNA synthesis and repair to stimulation of anabolism and cell proliferation through the mediation of insulin growthfactor 1 (IGF1) (39) . A healthy gut microbiota can produce relevant amounts of these substances, and also promote amino acid bioavailability. Conversely, dysbiosis may be associated with reduced production of these nutrients and absorption of amino acids, negatively influencing the muscle protein turnover (26) .
Other microbial metabolites, once absorbed into the circula tion, may act as endocrine mediators with a significant influence on skeletal muscle metabolism and function. The main of these mediators are represented by shortchain fatty acids (SCFAs), i.e. acetate, propionate and butyrate (11) . These substances are produced by specific microbial communities including Faecal ibacterium, Butyricimonas, Succinivibrio, Pseudosuccinivibrio and even some nonpathogenic Clostridia. They have a welldoc umented effect of insulinsensitivity promotion, modulation of inflammation, modulation of satiety and stimulation of adi pose tissue catabolism, ultimately resulting in proanabolic stimuli for the skeletal muscle cells (11) . In myocytes, acetate and propionate promote glucose uptake and activation of peroxi someproliferator activated receptors δ (PPARδ), resulting in in creased mitochondrial biogenesis (11) . Propionate also improves lipid mobilization from adipose tissue, with improved fatty acid oxidation in muscular mitochondria (11) . The administration of butyrate to aging mice determined significant improvements in skeletal muscle crosssectional area and overall lean mass, through a specific action of inhibition of the muscular enzyme histone deacetylase (48) . Gut microbiota dysbiosis is generally characterized by a selective depletion of SCFA producers, result ing in a possibly reduced proanabolic or anticatabolic effect for the skeletal muscle (39) .
A healthy gut microbiota may also transform some substanc es contained in foods into metabolically active mediators in fluencing muscle function. For example, a specific metabotype of human gut microbiota is able to transform the ellagitannins contained in pomegranates, nuts and raspberries into a com pound called urolithin A, exhibiting the capacity of improving muscle strength and exercise resistance in rats (36) .
On the other side, agerelated gut dysbiosis is associated with increased gut mucosa permeability, resulting in the penetra tion of bacterial toxins and even bacterial cells into the host circulation. These elements favor the activation of inflammatory response and promote chronic inflammation, representing one of the main mechanisms leading to muscle wasting (10) .
All these elements support the plausibility of the existence of a gutmuscle axis influencing the physiopathology of sar copenia. However, no human studies have confirmed this hypothesis to date. A single investigation, performed on Summary of the main mechanisms by which gut microbiota is able to influence the physio-pathology of distant organs, with a specific focus on the putative "gut-muscle axis".
MECHANISM POSSIBLE MEDIATORS RELEVANCE FOR THE SKELETAL MUSCLE Release of bacterial toxins into circulation
Lipopolysaccharide and other species-specific toxins Stimulation of chronic inflammation and immune system activation Darmmuskel-Achse im Alter mouse models of agerelated sarcopenia, has shown that sar copenic mice have distinct signatures in the fecal microbiota composition, with significant depletion of SCFAproducing taxa and reduced capacity of metabolizing amino acids (38) . These findings partly confirm gut "gutmuscle axis" hypothesis, but more studies are needed to verify the impact of gut microbiota on skeletal muscle function. In fact, the gut microbiota alter ations associated with sarcopenia may represent only a conse quence of the condition, and not an active player involved in its physiopathology (37) . However, the effects of gut microbiota manipulation through probiotics or functional foods on human skeletal muscle represent a promising area of research in the future. The interactive connections between physical function, cog nitive function, and microbiota should also be explored, since in aging physical function is strongly linked with cognition (24, 44) .
Diet represents another fundamental player in these com plex mechanisms. The studies performed on undernourished African children show that malnutrition is associated with profound alterations of gut microbiota towards dysbiosis (9) . Agerelated sarcopenia is often associated with malnutrition, especially in nursing home residents with mobility limitations or reduced access to physical activities (1) . In this context, the microbiome could represent a fundamental transducer of proanabolic stimuli from diet to skeletal muscle. In nurs ing home residents, lowquality diets and low nutrient intake could influence muscle mass wasting through mediation of intestinal microbiome (39) .
Moreover, recent evidence supports the beneficial role of exercise on the diversity and functionality of human intestinal microbiota (7), suggesting that the putative gutmuscle axis may function in both senses (39) . In animal models, the exercisein duced beneficial effects on gut microbiota allow to attenuate the pathological response to stressors, such as chemicallyinduced colitis (2) . These findings may imply that some of the benefits induced by physical exercise programs in cancer patients un dergoing active radio or chemotherapeutical treatment (30) are mediated by the gut microbiota, opening new, unexpected scenarios in the relationship between exercise, skeletal muscle and microbiota.
Conclusions and Perspectives
The existence of a gutmuscle axis in human physiopathology is highly plausible, especially in aging and agerelated skeletal muscle wasting conditions. Diet and microbial metabolism of nutrients play a central role on this putative gutmuscle axis. However, no human studies support this hypothesis at the cur rent literature stateofart.
Future studies should assess the composition and function ality of intestinal microbiota in muscle wasting disorders, and of course more research is needed before gut microbiota can represent a reasonable and valid therapeutical target in muscle diseases.
Futhermore, the interactive connections between diet, ex ercise and microbiome will also need careful investigation in the future. A healthy intestinal microbiota, as that associat ed with physical exercise, may act as a significant modifier of several physiopathological processes, involving the whole body and not limited to the gastrointestinal system. Converse ly, the hypothesis that at least some of the harmful effects of inactivity are mediated by the gut microbiota composi tion and functionality should be also tested for its important practical implications.
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